LUCD - Lucid Diagnostics Inc.
IEX Last Trade
0.7575
-0.013 -1.663%
Share volume: 0
Last Updated: Thu 26 Dec 2024 03:29:09 PM CET
Surgical and Medical Instrument Manufacturing :
0.83%
PREVIOUS CLOSE
CHG
CHG%
$0.77
-0.01
-1.64%
Fundamental analysis
25%
Profitability
25%
Dept financing
25%
Liquidity
23%
Performance
25%
Performance
5 Days
-2.14%
1 Month
-22.04%
3 Months
0.59%
6 Months
-7.92%
1 Year
-45.41%
2 Year
-36.83%
Key data
Stock price
$0.76
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.68 - $1.58
52 WEEK CHANGE
-$46.92
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
Company detail
CEO: Lishan Aklog
Region: US
Website: luciddx.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: luciddx.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Lucid Diagnostics Inc. focuses on patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux or simply reflux. The company was incorporated in 2018 and is based in New York, New York.
Recent news